Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Int J Neurosci ; 133(10): 1120-1123, 2023 Dec.
Article in English | MEDLINE | ID: mdl-35369847

ABSTRACT

Background: Transverse myelitis (TM) is a rare, acquired neuro-immunological spinal cord disorder that occurs with rapid onset of motor weakness, sensory deficits with bowel and bladder dysfunction. Patients being treated with immune checkpoint inhibitors (ICIs) for advanced malignancy have a known higher propensity of developing neuro immune complications. With the advent of COVID-19 pandemic there have been reported cases of TM with COVID-19 immunization. The reported infrequency of TM with both of the aforementioned causes makes delineation of the etiology challenging.Methods: We present a patient with metastatic small cell lung cancer (SCLC) on maintenance Atezolizumab immunotherapy who developed longitudinal extensive transverse myelitis (LETM) after administration of second dose of COVID-19 mRNA vaccine one day prior to presenting symptoms of acute paralysis of the lower extremity, sensory loss from chest down with overflow incontinence. A clinical diagnosis of myelopathy was supported by MRI of the spine illustrating enhancing lesions from C7-T7 concerning for LETM.Results: A 5-day course of pulsed methylprednisolone followed by therapeutic plasma exchange for 3 days resulted in only minimal improvement in the neurologic exam with increased strength in his lower extremities while the sensory level remained unchanged.Conclusions: This case demonstrates the complication and symptomatology of TM in the setting of anti-PD-L1 monoclonal antibody with coincidental COVID-19 mRNA vaccine administration. The causal relationship between the vaccine and LETM is difficult to establish. However, the presence of a known inciting factor hints at a possible exaggeration of the existing neuro-inflammatory process.


Subject(s)
COVID-19 , Myelitis, Transverse , Spinal Cord Diseases , Humans , Myelitis, Transverse/chemically induced , Myelitis, Transverse/therapy , COVID-19 Vaccines/adverse effects , Pandemics , COVID-19/complications , Immunization/adverse effects
2.
Cureus ; 15(12): e51123, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38274926

ABSTRACT

Rapidly progressive dementia (RPD) is caused by a heterogeneous group of neurological disorders, and the prototype is Creutzfeldt-Jakob disease (CJD). However, treatable causes including autoimmune encephalitis are often underrecognized and undertreated. A 72-year-old female patient was admitted with a 10-month history of rapidly progressive cognitive decline, visual hallucinations, paranoid behavior, diarrhea, and an 18-kg unintentional weight loss. On the physical exam, she was only oriented to the person and demonstrated an exaggerated startle response with diffuse rigidity. The initial clinical suspicion included CJD versus autoimmune encephalitis. Comprehensive laboratory testing, thyroid peroxidase, thyroglobulin antibodies, and autoimmune encephalitis panel were negative. The EEG showed mild to moderate diffuse slowing without any epileptiform abnormalities. An MRI brain revealed mild hippocampal atrophy. CSF testing revealed mild lymphocytic pleocytosis; RT-QuIC analysis and 14-3-3 protein were negative. There was no clinical improvement after treatment with IV steroids and IVIG. Repeated autoimmune encephalitis panel testing performed on a research basis was positive for dipeptidyl-peptidase-like protein 6 (DPPX) antibodies in serum and CSF. Unfortunately, our patient passed away before additional treatment could be attempted. Anti-DPPX encephalitis is a rare autoimmune disorder and an unrecognized cause of RPD. Early diagnosis and rapid escalation of treatment are imperative to avoid devastating neurological consequences.

3.
Open Forum Infect Dis ; 9(7): ofac236, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35854998

ABSTRACT

Cryptococcus gattii is an underrecognized cause of meningitis, especially in nonendemic regions. This report details C gattii disease progression from admission to autopsy in an otherwise healthy 40-year-old male in Texas. It brings awareness to an often unsuspected organism that can cause severe infection requiring early recognition and treatment in immunocompetent individuals.

4.
BMJ Open ; 11(11): e053487, 2021 11 18.
Article in English | MEDLINE | ID: mdl-34794996

ABSTRACT

OBJECTIVE: Opioid and benzodiazepine co-prescribing is associated with a substantial increase in opioid overdose deaths. In this study, we examine the prescribing trends of substitutes of opioids and benzodiazepines alone or in combination, compared with opioids and benzodiazepines. DESIGN: Retrospective cohort study. SETTING: Data were collected using a 20% national sample of Medicare beneficiaries from 2013 to 2018. PARTICIPANTS: 4.1-4.3 million enrollees each year from 2013 to 2018. INTERVENTION: None. PRIMARY OUTCOME: We employ a generalised linear mixed models to calculate ORs for opioid use, benzodiazepine or Z-drug (benzos/Z-drugs) use, opioid/benzos/Z-drugs 30-day use, gabapentinoid use and (selective serotonin reuptake inhibitors (SSRI) and serotonin norepinephrine reuptake inhibitors (SNRIs)) use, adjusted for the repeated measure of patient. We then created two models to calculate the ORs for each year and comparing to 2013. RESULTS: Opioid and benzos/Z-drugs use decreased by 2018 (aOR 0.626; 95% CI 0.622 to 0.630) comparing to 2013. We demonstrate a 36.3% and 9.9% increase rate of gabapentinoid and SSRI/SNRI use, respectively. Furthermore, combined gabapentinoid and SSRI/SNRI use increased in 2018 (aOR 1.422; 95% CI 1.412 to 1.431). CONCLUSION: Little is known about the prescribing pattern and trend of opioid and benzodiazepine alternatives as analgesics. There is a modest shift from prescribing opioid and benzos/Z-drugs (alone or in combination) towards prescribing non-opioid analgesics-gabapentinoids with and without non-benzos/Z-drugs that are indicated for anxiety. It is unclear if this trend towards opioid/benzos/Z-drugs alternatives is associated with fewer drug overdose death, better control of pain and comorbid anxiety, and improved quality of life.


Subject(s)
Drug Overdose , Medicare Part D , Aged , Analgesics, Opioid/therapeutic use , Benzodiazepines/therapeutic use , Drug Overdose/drug therapy , Humans , Practice Patterns, Physicians' , Quality of Life , Retrospective Studies , United States
5.
Clin Neuropharmacol ; 44(2): 75-76, 2021.
Article in English | MEDLINE | ID: mdl-33480615

ABSTRACT

BACKGROUND: Gabapentin is a commonly used medication for neuropathic pain and epilepsy that is prescribed by a wide range of medical specialties. Adverse effects including asterixis and myoclonus have been described in patients with chronic kidney disease, but myokymia has not been previously reported. CASE PRESENTATION: A 69-year-old man with a history of traumatic brain injury, peripheral neuropathy, amnesia, and posttraumatic stress disorder presented to the hospital after multiple falls attributed to acute onset muscle spasms. He reported taking a total daily dose of 9600 mg of gabapentin, as prescribed. Physical examination demonstrated stimulus-sensitive myoclonus, painful muscle spasms in all extremities, and myokymia in his bilateral calves. Diffuse action tremors, as well as tongue tremors, were also observed.Initial workup, including basic laboratory investigations, brain imaging, and electroencephalogram, was unrevealing. Gabapentin toxicity was suspected, and a gabapentin holiday was initiated with the improvement of myokymia by hospital day 3. The patient was found to have a high gabapentin level (25.8 µg/mL; reference range, 2.0-20.0 µg/mL) measured the morning after hospital presentation. After restarting on a lower dose of gabapentin with multimodal pain control, the patient continued to improve with diminution of his myoclonus, tremor, and gait instability. CONCLUSIONS: Myokymia is a newly described motor symptom associated with gabapentin toxicity. The mechanism of gabapentin-associated myokymia is currently unknown. A brief medication holiday resulted in the resolution of motor symptoms without significant withdrawal symptoms. Knowledge of this newly reported adverse manifestation can aid physicians in the diagnosis of gabapentin toxicity and prompt treatment, as gabapentin levels are not widely or immediately available.


Subject(s)
Cyclohexanecarboxylic Acids , Myokymia , Aged , Amines/adverse effects , Animals , Cattle , Cyclohexanecarboxylic Acids/adverse effects , Gabapentin , Humans , Male , gamma-Aminobutyric Acid/adverse effects
6.
J Clin Neurosci ; 59: 1-5, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30401568

ABSTRACT

Elderly individuals are a fast-rising segment of the US population and are at high risk of permanent disability and premature death secondary to traumatic injuries such as burn injury. The current paper will review the extant literature to understand the prevalence of burn injury in the elderly, the neurocognitive complications unique to the aged that places this cohort at risk, and evidence-based recommendations to reduce the early and late neurocognitive effects of burn injury in the aged. The elderly are a high-risk population for burn injury and its neurological sequela. This risk, at least in part, reflects multiple factors: age-related changes in the central and peripheral nervous system; multiple pre-existing co-morbidities (such as dementia and COPD); polypharmacy; suboptimal social support; and increased susceptibility to hypothermia, burn-related infections, and electrolyte and metabolic dysregulations.


Subject(s)
Aging/pathology , Burns/epidemiology , Dementia/epidemiology , Aged , Aged, 80 and over , Burns/prevention & control , Dementia/rehabilitation , Evidence-Based Practice , Humans , Neurological Rehabilitation/methods
7.
Exp Lung Res ; 37(4): 239-45, 2011 May.
Article in English | MEDLINE | ID: mdl-21309735

ABSTRACT

Inhalation injury frequently occurs in burn patients and contributes to the morbidity and mortality of these injuries. Arterial carboxyhemoglobin has been proposed as an indicator of the severity of inhalation injury; however, the interrelation between arterial carboxyhemoglobin and histological alterations has not yet been investigated. Chronically instrumented sheep were subjected to a third degree burn of 40% of the total body surface area and inhalation of 48 breaths of cotton smoke. Carboxyhemoglobin was measured immediately after injury and correlated to clinical parameters of pulmonary function as well as histopathology scores from lung tissue harvested 24 hours after the injury. The injury was associated with a significant decline in pulmonary oxygenation and increases in pulmonary shunting, lung lymph flow, wet/dry weight ratio, congestion score, edema score, inflammation score, and airway obstruction scores. Carboxyhemoglobin was negatively correlated to pulmonary oxygenation and positively correlated to pulmonary shunting, lung lymph flow, and lung wet/dry weight ratio. No significant correlations could be detected between carboxyhemoglobin and histopathology scores and airway obstruction scores. Arterial carboxyhemoglobin in sheep with combined burn and inhalation injury are correlated with the degree of pulmonary failure and edema formation, but not with certain histological alterations including airway obstruction scores.


Subject(s)
Burns/pathology , Carboxyhemoglobin/analysis , Predictive Value of Tests , Smoke Inhalation Injury/pathology , Animals , Body Surface Area , Lung Injury , Sheep
8.
Am J Physiol Lung Cell Mol Physiol ; 300(2): L167-75, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21075825

ABSTRACT

During acute lung injury, nitric oxide (NO) exerts cytotoxic effects by reacting with superoxide radicals, yielding the reactive nitrogen species peroxynitrite (ONOO(-)). ONOO(-) exerts cytotoxic effects, among others, by nitrating/nitrosating proteins and lipids, by activating the nuclear repair enzyme poly(ADP-ribose) polymerase and inducing VEGF. Here we tested the effect of the ONOO(-) decomposition catalyst INO-4885 on the development of lung injury in chronically instrumented sheep with combined burn and smoke inhalation injury. The animals were randomized to a sham-injured group (n = 7), an injured control group [48 breaths of cotton smoke, 3rd-degree burn of 40% total body surface area (n = 7)], or an injured group treated with INO-4885 (n = 6). All sheep were mechanically ventilated and fluid-resuscitated according to the Parkland formula. The injury-related increases in the abundance of 3-nitrotyrosine, a marker of protein nitration by ONOO(-), were prevented by INO-4885, providing evidence for the neutralization of ONOO(-) action by the compound. Burn and smoke injury induced a significant drop in arterial Po(2)-to-inspired O(2) fraction ratio and significant increases in pulmonary shunt fraction, lung lymph flow, lung wet-to-dry weight ratio, and ventilatory pressures; all these changes were significantly attenuated by INO-4885 treatment. In addition, the increases in IL-8, VEGF, and poly(ADP-ribose) in lung tissue were significantly attenuated by the ONOO(-) decomposition catalyst. In conclusion, the current study suggests that ONOO(-) plays a crucial role in the pathogenesis of pulmonary microvascular hyperpermeability and pulmonary dysfunction following burn and smoke inhalation injury in sheep. Administration of an ONOO(-) decomposition catalyst may represent a potential treatment option for this injury.


Subject(s)
Burns/drug therapy , Burns/physiopathology , Metalloporphyrins/therapeutic use , Peroxynitrous Acid/metabolism , Smoke Inhalation Injury/drug therapy , Smoke Inhalation Injury/physiopathology , Animals , Burns/complications , Capillary Permeability/drug effects , Catalysis , Disease Models, Animal , Female , Hemodynamics/drug effects , Interleukin-8/metabolism , Lung/drug effects , Lung/physiopathology , Peroxidase/metabolism , Peroxynitrous Acid/toxicity , Poly(ADP-ribose) Polymerases/metabolism , Pulmonary Circulation/drug effects , Sheep , Smoke Inhalation Injury/complications , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Vascular Endothelial Growth Factor A/metabolism
9.
Anesthesiology ; 113(6): 1376-84, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21068663

ABSTRACT

BACKGROUND: Recent evidence suggests that nitric oxide produced via the neuronal nitric oxide synthase is involved mainly in the early response to sepsis, whereas nitric oxide derived from the inducible nitric oxide synthase is responsible during the later phase. We hypothesized that early neuronal and delayed inducible nitric oxide synthase blockade attenuates multiple organ dysfunctions during sepsis. METHODS: Sheep were randomly allocated to sham-injured, nontreated animals (n = 6); injured (48 breaths of cotton smoke and instillation of Pseudomonas aeruginosa into the lungs), nontreated animals (n = 7); and injured animals treated with a neuronal nitric oxide synthase inhibitor from 1 to 12 h and an inducible nitric oxide synthase inhibitor from 12 to 24 h postinjury (n = 6). RESULTS: The injury induced arterial hypotension, vascular leakage, myocardial depression, and signs of renal and hepatic dysfunctions. The treatment significantly attenuated, but did not fully prevent, the decreases in mean arterial pressure and left ventricular stroke work index. Although the elevation of creatinine levels was partially prevented, the decreases in urine output and creatinine clearance were not affected. The injury-related increases in bilirubin levels, international normalized ratio, and lipid peroxidation in liver tissue were significantly attenuated. Although plasma nitrite/nitrate levels were significantly increased versus baseline from 12-24 h in controls, plasma nitrite/nitrate levels were not increased in treated animals. CONCLUSIONS: The combination treatment shows potential benefit on sepsis-related arterial hypotension and surrogate parameters of organ dysfunctions in sheep. It may be crucial to identify the time course of expression and activation of different nitric oxide synthase isoforms in future investigations.


Subject(s)
Cardiovascular Diseases/drug therapy , Cardiovascular Diseases/etiology , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Kidney Diseases/drug therapy , Kidney Diseases/etiology , Liver Diseases/drug therapy , Liver Diseases/etiology , Nitric Oxide Synthase Type III/antagonists & inhibitors , Nitric Oxide Synthase Type II/antagonists & inhibitors , Sepsis/complications , Animals , Blood Chemical Analysis , Body Temperature , Cardiovascular Diseases/physiopathology , Female , Hemodynamics/drug effects , Hemodynamics/physiology , Kidney Diseases/physiopathology , Kidney Function Tests , Leukocyte Count , Liver Diseases/physiopathology , Liver Function Tests , Multiple Organ Failure/drug therapy , Multiple Organ Failure/etiology , Multiple Organ Failure/physiopathology , Oxidative Stress/physiology , Pseudomonas Infections/drug therapy , Pseudomonas Infections/microbiology , Sepsis/physiopathology , Sheep
10.
Biochem Biophys Res Commun ; 399(2): 286-91, 2010 Aug 20.
Article in English | MEDLINE | ID: mdl-20655878

ABSTRACT

Excessive production of nitric oxide (NO) by NO synthase (NOS) with subsequent formation of peroxynitrite and poly(adenosine diphosphate ribose) is critically implemented in the pathophysiology of acute lung injury and sepsis. To elucidate the roles of different isoforms of NOS, we tested the effects of non-selective NOS inhibition and neuronal NOS (nNOS)- and inducible NOS (iNOS)-gene deficiency on the pulmonary oxidative and nitrosative stress reaction in a murine sepsis model. The injury was induced by four sets of cotton smoke using an inhalation chamber and subsequent intranasal administration of live Pseudomonas aeruginosa (3.2x10(7) colony-forming units). In wild type mice, the injury was associated with excessive releases of pro-inflammatory cytokines in the plasma, enhanced neutrophil accumulation, increased lipid peroxidation, and excessive formation of reactive nitrogen species and vascular endothelial growth factor in the lung. Both nNOS- and iNOS-gene deficiency led to significantly reduced oxidative and nitrosative stress markers in the lung, but failed to significantly improve survival. Treatment with a non-selective NOS inhibitor failed to reduce the oxidative and nitrosative stress reaction to the same extent and even tended to increase mortality. In conclusion, the current study demonstrates that both nNOS and iNOS are partially responsible for the pulmonary oxidative and nitrosative stress reaction in this model. Future studies should investigate the effects of specific pharmacological inhibition of nNOS and iNOS at different time points during the disease process.


Subject(s)
Acute Lung Injury/enzymology , Nitric Oxide Synthase Type II/physiology , Nitric Oxide Synthase Type I/physiology , Sepsis/enzymology , Acute Lung Injury/chemically induced , Acute Lung Injury/microbiology , Animals , Disease Models, Animal , Edema/enzymology , Female , Mice , Nitric Oxide Synthase Type I/antagonists & inhibitors , Nitric Oxide Synthase Type I/genetics , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide Synthase Type II/genetics , Oxidative Stress/genetics , Pseudomonas aeruginosa , Reactive Nitrogen Species/metabolism
11.
Crit Care ; 14(4): R129, 2010.
Article in English | MEDLINE | ID: mdl-20602787

ABSTRACT

INTRODUCTION: Different isoforms of nitric oxide synthases (NOS) and determinants of oxidative/nitrosative stress play important roles in the pathophysiology of pulmonary dysfunction induced by acute lung injury (ALI) and sepsis. However, the time changes of these pathogenic factors are largely undetermined. METHODS: Twenty-four chronically instrumented sheep were subjected to inhalation of 48 breaths of cotton smoke and instillation of live Pseudomonas aeruginosa into both lungs and were euthanized at 4, 8, 12, 18, and 24 hours post-injury. Additional sheep received sham injury and were euthanized after 24 hrs (control). All animals were mechanically ventilated and fluid resuscitated. Lung tissue was obtained at the respective time points for the measurement of neuronal, endothelial, and inducible NOS (nNOS, eNOS, iNOS) mRNA and their protein expression, calcium-dependent and -independent NOS activity, 3-nitrotyrosine (3-NT), and poly(ADP-ribose) (PAR) protein expression. RESULTS: The injury induced severe pulmonary dysfunction as indicated by a progressive decline in oxygenation index and concomitant increase in pulmonary shunt fraction. These changes were associated with an early and transient increase in eNOS and an early and profound increase in iNOS expression, while expression of nNOS remained unchanged. Both 3-NT, a marker of protein nitration, and PAR, an indicator of DNA damage, increased early but only transiently. CONCLUSIONS: Identification of the time course of the described pathogenetic factors provides important additional information on the pulmonary response to ALI and sepsis in the ovine model. This information may be crucial for future studies, especially when considering the timing of novel treatment strategies including selective inhibition of NOS isoforms, modulation of peroxynitrite, and PARP.


Subject(s)
Nitric Oxide Synthase/metabolism , Poly Adenosine Diphosphate Ribose/metabolism , Sepsis/metabolism , Tyrosine/analogs & derivatives , Acute Lung Injury/metabolism , Acute Lung Injury/physiopathology , Animals , Disease Models, Animal , Interleukin-8/analysis , Interleukin-8/metabolism , Interleukin-8/physiology , Lung/chemistry , Lung/enzymology , Nitrates/blood , Nitric Oxide Synthase/physiology , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide Synthase Type II/physiology , Nitric Oxide Synthase Type III/metabolism , Nitric Oxide Synthase Type III/physiology , Nitrites/blood , Poly Adenosine Diphosphate Ribose/analysis , Poly Adenosine Diphosphate Ribose/physiology , Reverse Transcriptase Polymerase Chain Reaction , Sepsis/physiopathology , Sheep , Time Factors , Tyrosine/analysis , Tyrosine/metabolism , Tyrosine/physiology
12.
Tumour Biol ; 31(3): 181-7, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20393826

ABSTRACT

Breast cancer is the most common form of cancer among women. Compared with other serum polypeptides, autoantibodies have many appealing features as biomarkers including sensitivity, stability, and easy detection. Anti-lipid autoantibodies are routinely used in the diagnosis of autoimmune diseases, but their potential for cancer diagnosis has not been explored. Dysregulation of cellular signaling in cancer cells would be expected to lead to irregular metabolism of many lipids, which could be sensed by the immune system and cause the production of autoantibodies. Discovery of anti-lipid antibodies could be used as biomarkers for early breast cancer diagnosis. We describe here a more sensitive and accurate method for lipid microarray detection using dual fluorescent labeling, and used it to examine global anti-lipid profiles in the MMTV-Neu transgenic breast cancer model. We conclude that, at the current technology, lipid microarray is not a preferred method for anti-lipid antibody detection in breast cancer animal models. Our result will help the future application of lipid microarrays in identifying anti-lipid autoantibodies in breast cancer and other human diseases.


Subject(s)
Biomarkers, Tumor/blood , Breast Neoplasms/diagnosis , Lipids/immunology , Microarray Analysis/methods , Animals , Autoantibodies/blood , Autoantibodies/immunology , Biomarkers, Tumor/immunology , Breast Neoplasms/blood , Breast Neoplasms/immunology , Female , Mice
13.
Biochem Biophys Res Commun ; 391(3): 1555-60, 2010 Jan 15.
Article in English | MEDLINE | ID: mdl-20036639

ABSTRACT

Acute lung injury (ALI) by smoke inhalation with subsequent pneumonia and sepsis represents a major cause of morbidity and mortality in burn patients. The aim of the present study was to develop a murine model of ALI and sepsis to enhance the knowledge of mechanistic aspects and pathophysiological changes in patients with these injuries. In deeply anesthetized female C57BL/6 mice, injury was induced by four sets of cotton smoke using an inhalation chamber. Afterward, live Pseudomonas aeruginosa (3.2x10(7) colony-forming units) was administered intranasally. The indicated dose of bacteria was determined based on the results of a dose-response study (n=47). The following study groups were monitored for survival over 96h: (1) sham injury group, (2) only smoke inhalation group, (3) only bacteria group, and (4) smoke inhalation plus bacteria group. Each group included 10 mice. The survival rates were 100%, 90%, 30%, and 10%, respectively. The double hit injury was associated with excessive releases of pro-inflammatory cytokines in the plasma, and enhanced neutrophil accumulation, increased lipid peroxidation, and excessive formation of reactive nitrogen species in the lung. In mice receiving only smoke inhalation injury, no systemic cytokine release and increased lung tissue lipid peroxidation were observed. However, smoke alone significantly increased neutrophil accumulation and formation of reactive nitrogen species in lung tissue. In conclusion, bacterial pneumonia is predominantly responsible for mortality and morbidity in this novel murine model of smoke inhalation and pulmonary sepsis. Reactive oxygen and nitrogen species mediate the severity of lung injury.


Subject(s)
Acute Lung Injury/etiology , Disease Models, Animal , Mice , Opportunistic Infections/etiology , Sepsis/etiology , Smoke Inhalation Injury/complications , Acute Lung Injury/microbiology , Animals , Female , Mice, Inbred C57BL , Pseudomonas aeruginosa
14.
Br J Pharmacol ; 158(6): 1442-53, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19845680

ABSTRACT

BACKGROUND AND PURPOSE: The present study investigated whether the pathophysiological changes induced by burn and smoke inhalation are modulated by parenteral administration of Na(2)S, a H(2)S donor. EXPERIMENTAL APPROACH: The study used a total of 16 chronically instrumented, adult female sheep. Na(2)S was administered 1 h post injury, as a bolus injection at a dose of 0.5 mg.kg(-1) and subsequently, as a continuous infusion at a rate of 0.2 mg.kg(-1).h(-1) for 24 h. Cardiopulmonary variables (mean arterial and pulmonary arterial blood pressure, cardiac output, ventricular stroke work index, vascular resistance) and arterial and mixed venous blood gases were measured. Lung wet-to-dry ratio and myeloperoxidase content and protein oxidation and nitration were also measured. In addition, lung inducible nitric oxide synthase expression and cytochrome c were measured in lung homogenates via Western blotting and enzyme-linked immunosorbent assay (elisa) respectively. KEY RESULTS: The H(2)S donor decreased mortality during the 96 h experimental period, improved pulmonary gas exchange and lowered further increase in inspiratory pressure and fluid accumulation associated with burn- and smoke-induced acute lung injury. Further, the H(2)S donor treatment reduced the presence of protein oxidation and 3-nitrotyrosine formation following burn and smoke inhalation injury. CONCLUSIONS AND IMPLICATIONS: Parenteral administration of the H(2)S donor ameliorated the pulmonary pathophysiological changes associated with burn- and smoke-induced acute lung injury. Based on the effect of H(2)S observed in this clinically relevant model of disease, we propose that treatment with H(2)S or its donors may represent a potential therapeutic strategy in managing patients with acute lung injury.


Subject(s)
Acute Lung Injury/drug therapy , Hydrogen Sulfide/metabolism , Smoke Inhalation Injury/drug therapy , Sulfides/pharmacology , Acute Lung Injury/etiology , Acute Lung Injury/mortality , Animals , Blotting, Western , Burns/complications , Cytochromes c/metabolism , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Nitric Oxide Synthase Type II/metabolism , Sheep , Smoke Inhalation Injury/mortality , Smoke Inhalation Injury/physiopathology
15.
Shock ; 32(6): 621-5, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19295474

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) infections with severe outcomes such as sepsis and septic shock are progressively increasing in both the community and in hospital settings. We hypothesized that overexpression of reactive nitrogen and oxygen species and vascular endothelial growth factor (VEGF) play a pivotal role in cardiovascular collapse associated with vascular hyperpermeability in MRSA sepsis. Twelve sheep were surgically prepared and randomized into a control (noninjured; n = 6) and a sepsis (injured; n = 6) group. Animals in the sepsis group were subjected to cotton smoke inhalation and instillation of 2.5 x 10(11) colony-forming units of live MRSA into both lungs. Cardiovascular variables in the control group remained stable, whereas the MRSA sepsis group developed a hypotensive and hyperdynamic circulatory shock state beginning at 6 h associated with significantly increased vascular permeability evidenced by increased prefemoral lymph flow starting at 12 h and permeability index from 12 to 18 h, higher fluid accumulation from 12 to 24 h, and significantly decreased plasma protein concentration and oncotic pressure beginning at 6 h compared with control animals. Myocardial 3-nitrotyrosine (3-NT) protein, poly (adenosine diphosphate-ribose), and VEGF mRNA expressions measured after the 24-h experiment were significantly increased in the injured animals as well. These results evidence that excessive production of reactive radicals and VEGF may play a major role in cardiovascular collapse and vascular hyperpermeability in MRSA sepsis.


Subject(s)
Capillary Permeability , Sepsis/microbiology , Sepsis/physiopathology , Staphylococcus aureus/metabolism , Animals , Cardiovascular System/injuries , Drug Resistance, Bacterial , Free Radicals , Heart/microbiology , Lung/microbiology , Methicillin/pharmacology , RNA, Messenger/metabolism , Sheep, Domestic , Shock, Septic/physiopathology , Time Factors , Vascular Endothelial Growth Factor A/metabolism
16.
Crit Care Med ; 37(1): 223-9, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19050630

ABSTRACT

OBJECTIVE: Acute lung injury with subsequent pneumonia and sepsis represents a major cause of morbidity and mortality in thermally injured patients. Production of nitric oxide by the neuronal and inducible nitric oxide synthase may be critically involved in the pathophysiology of the disease process at different time points, and thus specific inhibition at different times may represent an effective treatment regimen. DESIGN: Prospective, controlled, randomized trial. SETTING: University research laboratory. SUBJECTS: Eighteen chronically instrumented, adult, female sheep. INTERVENTIONS: Following baseline measurements, the animals were allocated to either sham-injured, nontreated controls (sham), injured, nontreated controls (control), or injured animals treated with continuous infusion of 7-nitroindazole, a specific neuronal nitric oxide synthase inhibitor, during the first 12 hrs postinjury and infusion of BBS-2, a specific inducible nitric oxide synthase inhibitor, during the next 12 hrs. Injury was induced by 48 breaths of cotton smoke and subsequent instillation of Pseudomonas aeruginosa into the lungs. All sheep were mechanically ventilated and fluid resuscitated for the entire duration of the 24-hr experiment. MEASUREMENTS AND MAIN RESULTS: The injury induced severe pulmonary dysfunction, which was associated with increases in lung edema formation, airway obstruction, and vascular endothelial growth factor, 3-nitrotyrosine, and poly(adenosine diphosphate ribose) expression in lung tissue. The treatment reduced the degree of airway obstruction and improved pulmonary gas exchange, whereas the development of lung edema was not affected. The increases in lung tissue vascular endothelial growth factor, 3-nitrotyrosine, and poly(ribose) expression were attenuated by the treatment. CONCLUSIONS: The combination of early neuronal nitric oxide synthase and delayed inducible nitric oxide synthase inhibition shows potential benefit in ovine acute lung injury by reducing nitrosative stress in the lung and limiting the degree of airway obstruction.


Subject(s)
Acute Lung Injury/drug therapy , Enzyme Inhibitors/therapeutic use , Imidazoles/therapeutic use , Indazoles/therapeutic use , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide Synthase Type I/antagonists & inhibitors , Piperazines/therapeutic use , Pyrimidines/therapeutic use , Acute Lung Injury/enzymology , Animals , Female , Sheep
17.
Crit Care Med ; 36(4): 1284-9, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18379256

ABSTRACT

OBJECTIVE: To assess the time changes and mechanism of pulmonary and peripheral vascular permeability in sheep with acute lung injury and sepsis. DESIGN: Prospective, controlled, randomized trial. SETTING: University research laboratory. SUBJECTS: A total of 21 chronically instrumented, adult female sheep. INTERVENTIONS: Sheep were instrumented with lung and prefemoral lymph fistulas and allocated to either an uninjured control group (n = 5) or sepsis group (n = 5). The sheep in the sepsis group received cotton smoke inhalation injury followed by instillation of Pseudomonas aeruginosa into the lungs. All sheep were mechanically ventilated and fluid resuscitated for the entire duration of the 24-hr experiment. Additional sheep (n = 11) received injury and were killed at different time points for the measurement of vascular endothelial growth factor in lung tissue. MEASUREMENTS AND MAIN RESULTS: The injury induced a hypotensive-hyperdynamic circulation; increases in pulmonary capillary pressure, net fluid balance, lung and prefemoral lymph flow and protein content, lung water content, abdominal and thoracic fluid and protein content, neutrophil accumulation in the lung, and vascular endothelial growth factor expression in lung tissue; and decreases in PaO2/FiO2 ratio, plasma protein concentration, plasma oncotic pressure, and myocardial contractility. CONCLUSIONS: Lung edema formation in this model was the result of marked increases in both pulmonary microvascular permeability and pressure. Pulmonary vascular hyperpermeability peaked 12 hrs postinjury and was related to vascular endothelial growth factor overexpression. Early myocardial failure was a potential contributor to the constant increase in pulmonary capillary pressure. The sepsis-induced increase in peripheral microvascular permeability was associated with significant accumulation of fluid and protein in the third space.


Subject(s)
Capillary Permeability , Disease Models, Animal , Respiratory Distress Syndrome/physiopathology , Sepsis/physiopathology , Animals , Female , Hemodynamics , Pseudomonas aeruginosa , Respiratory Distress Syndrome/metabolism , Sepsis/metabolism , Sepsis/microbiology , Sheep , Vascular Endothelial Growth Factor A/metabolism
18.
J Appl Physiol (1985) ; 105(2): 678-84, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18436699

ABSTRACT

The morbidity and mortality of burn victims increase when burn injury is combined with smoke inhalation. The goal of the present study was to develop a murine model of burn and smoke inhalation injury to more precisely reveal the mechanistic aspects of these pathological changes. The burn injury mouse group received a 40% total body surface area third-degree burn alone, the smoke inhalation injury mouse group received two 30-s exposures of cotton smoke alone, and the combined burn and smoke inhalation injury mouse group received both the burn and the smoke inhalation injury. Animal survival was monitored for 120 h. Survival rates in the burn injury group, the smoke inhalation injury group, and the combined injury group were 70%, 60%, and 30%, respectively. Mice that received combined burn and smoke injury developed greater lung damage as evidenced by histological changes (septal thickening and interstitial edema) and higher lung water content. These mice also displayed more severely impaired pulmonary gas exchange [arterial PO2 (PaO2)/inspired O2 fraction (FiO2)<200]. Lung myeloperoxidase activity was significantly higher in burn and smoke-injured animals compared with the other three experimental groups. Plasma NO2-/NO3-, lung inducible nitric oxide synthase (iNOS) activity, and iNOS mRNA increased with injury; however, the burn and smoke injury group exhibited a higher response. Severity of burn and smoke inhalation injury was associated with more pronounced production of nitric oxide and accumulation of activated leukocytes in lung tissue. The murine model of burn and smoke inhalation injury allows us to better understand pathophysiological mechanisms underlying cardiopulmonary morbidity secondary to burn and smoke inhalation injury.


Subject(s)
Burns/physiopathology , Lung/physiopathology , Smoke Inhalation Injury/physiopathology , Animals , Burns/pathology , Female , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Lung/pathology , Mice , Mice, Inbred C57BL , Nitric Oxide/blood , Nitric Oxide Synthase Type II/biosynthesis , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Organ Size , Peroxidase/metabolism , Pulmonary Gas Exchange , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Smoke Inhalation Injury/pathology
19.
Clin Sci (Lond) ; 115(3): 91-7, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18315525

ABSTRACT

Acute lung injury results in a severe inflammatory response, which leads to priming and activation of leucocytes, release of reactive oxygen and reactive nitrogen species, destruction of pulmonary endothelium, extravasation of protein-rich fluid into the interstitium and formation of oedema. Recently, H2S (hydrogen sulfide) has been shown to decrease the synthesis of pro-inflammatory cytokines, reduce leucocyte adherence to the endothelium and subsequent diapedesis of these cells from the microvasculature in in vivo studies, and to protect cells in culture from oxidative injury. In the present study, we hypothesized that a parenteral formulation of H2S would reduce the lung injury induced by burn and smoke inhalation in a novel murine model. H(2)S post-treatment significantly decreased mortality and increased median survival in mice. H2S also inhibited IL (interleukin)-1beta levels and significantly increased the concentration of the anti-inflammatory cytokine IL-10 in lung tissue. Additionally, H2S administration attenuated protein oxidation following injury and improved the histological condition of the lung. In conclusion, these results suggest that H2S exerts protective effects in acute lung injury, at least in part through the activation of anti-inflammatory and antioxidant pathways.


Subject(s)
Burns/complications , Hydrogen Sulfide/therapeutic use , Respiratory Distress Syndrome/prevention & control , Animals , Disease Models, Animal , Drug Evaluation, Preclinical , Female , Inflammation Mediators/metabolism , Interleukin-10/metabolism , Interleukin-1beta/metabolism , Lung/metabolism , Mice , Mice, Inbred C57BL , Oxidative Stress/drug effects , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/metabolism , Respiratory Distress Syndrome/pathology , Smoke Inhalation Injury/complications , Smoke Inhalation Injury/metabolism , Smoke Inhalation Injury/pathology
20.
Clin Sci (Lond) ; 114(4): 321-9, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17927568

ABSTRACT

Burn and smoke inhalation-related multiple organ dysfunction is associated with a severe fall in the plasma concentration of antithrombin. Therefore the aim of the present study was to test the hypothesis that intravenous administration of recombinant human antithrombin in combination with aerosolized heparin will ameliorate acute lung injury in sheep exposed to cutaneous burn and smoke inhalation. Sheep were prepared operatively for study and, 7 days post-surgery, sheep were given a cutaneous burn (40% of total body surface area, third-degree burn) and insufflated with cotton smoke (48 breaths, <40 degrees C) under halothane anaesthesia. After injury, sheep were placed on a ventilator and resuscitated with Ringer's lactate solution. The animals were divided into three groups: sham group (non-injured and non-treated; n=6), saline group (injured and received saline; n=6) and rhAT.iv.+Hep group [injured and treated with rhAT (recombinant human antithrombin) and heparin; n=6]. In the rhAT.iv.+Hep group, rhAT was infused continuously for 48 h starting 1 h post-injury with a dose of 0.34 mg.h(-1).kg(-1) of body weight and heparin (10000 units) was aerosolized every 4 h starting at 1 h post-injury. The experiment lasted 48 h. Haemodynamics were stable in sham group, whereas the saline-treated sheep developed multiple signs of acute lung injury, including decreased pulmonary gas exchange, increased inspiratory pressures, extensive airway obstruction and increased pulmonary oedema. These pathological changes were associated with a severe fall in plasma antithrombin concentration, lung tissue accumulation of leucocytes and excessive production of NO. Treatment of injured sheep with anticoagulants attenuated all of the pulmonary pathophysiology observed. In conclusion, the results provide definitive evidence that anticoagulant therapy may be a novel and effective treatment tool in the management of burn patients with concomitant smoke inhalation injury.


Subject(s)
Anticoagulants/administration & dosage , Antithrombins/administration & dosage , Burns/drug therapy , Fibrinolytic Agents/administration & dosage , Heparin/administration & dosage , Smoke Inhalation Injury/drug therapy , Aerosols , Animals , Anticoagulants/therapeutic use , Antithrombins/therapeutic use , Burns/metabolism , Burns/pathology , Burns, Inhalation , Female , Fibrinolytic Agents/therapeutic use , Heparin/therapeutic use , Humans , Injections, Intravenous , Leukocytes/immunology , Lung/immunology , Lung/metabolism , Lung/pathology , Models, Animal , Nitric Oxide/metabolism , Peroxidase/metabolism , Pulmonary Edema/pathology , Pulmonary Edema/prevention & control , Recombinant Proteins/administration & dosage , Recombinant Proteins/therapeutic use , Resuscitation , Sheep , Skin/injuries , Smoke Inhalation Injury/metabolism , Smoke Inhalation Injury/pathology , Vascular Endothelial Growth Factor A/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...